CobiCure, a non-profit company of Advancium Health Network, is committed to addressing critical gaps in pediatric healthcare through a comprehensive ecosystem, innovating both medical devices and treatments for childhood cancers and rare diseases to meaningfully impact children and families. Explore our dual missions in MedTech and Therapeutics:
CobiCure’s name is rooted in a deep commitment to pediatric healthcare innovation, drawing inspiration from two distinct but connected sources.
“Cobi,” honors Dr. Abraham Jacobi. Widely recognized as the father of American pediatrics throughout the nineteenth century, Jacobi's early, trailblazing approach to children’s medicine left an enduring legacy. We seek to embody the same pioneering spirit and dedication to advancing pediatrics.
“Cure” reflects the company’s mission to accelerate tangible impact for childhood cancers and rare, congenital diseases. It also is a nod to our headquarters located within the globally recognized Cure building in the heart of New York City, a space dedicated to healthcare innovation and collaboration.
Together, "CobiCure" stands as a symbol of hope, determination, and a relentless pursuit to make critical progress in pediatric healthcare.
We are a team of diverse experts committed to eliminating barriers in healthcare for children and patients with rare diseases.
MARK VEICH
CEO
MICHELE CLEARY
Chief Scientific Officer
ROBERT OLAN
VP, Business Development
EMMA MORAN
Head of CobiCure MedTech
MAUREEN REYES
Director of Strategy & Operations
SCHUYLER KENNEDY
Associate Director of Business Development & Operations
CobiCure is part of the Advancium Health Network, a public charity launched in 2021 by Deerfield Management and the Deerfield Foundation. It is dedicated to tackling healthcare’s most daunting gaps for underserved patients through strategic partnerships, philanthropic support, and industry expertise.
Meet the rest of our team at Advancium Health Network:
.png)
